Tower Research Capital LLC (Trc) Haemonetics Corp Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Haemonetics Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,049 shares of HAE stock, worth $230,016. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,049
Previous 11,088
72.5%
Holding current value
$230,016
Previous $917,000
73.28%
% of portfolio
0.01%
Previous 0.02%
Shares
29 transactions
Others Institutions Holding HAE
# of Institutions
332Shares Held
53.8MCall Options Held
689KPut Options Held
345K-
Black Rock Inc. New York, NY5.96MShares$450 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.17MShares$390 Million0.01% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.44MShares$335 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA4.2MShares$317 Million0.06% of portfolio
-
Neuberger Berman Group LLC New York, NY4.03MShares$304 Million0.26% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.87B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...